Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation

[1]  R. Klement.  The influence of ketogenic therapy on the 5 R’s of radiobiology , 2019, International journal of radiation biology.

[2]  D. Wiederschain,et al.  Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition , 2017, PloS one.

[3]  Xiaofeng Dai,et al.  Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping , 2017, Journal of Cancer.

[4]  Nicola Zamboni,et al.  Metabotypes of breast cancer cell lines revealed by non-targeted metabolomics. , 2017, Metabolic engineering.

[5]  F. Filipp,et al.  Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities , 2017, Cancer & Metabolism.

[6]  T. Seyfried,et al.  Efficacy of Metabolically Supported Chemotherapy Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy for Stage IV Triple-Negative Breast Cancer , 2017, Cureus.

[7]  F. Vizeacoumar,et al.  Molecular characterization of breast cancer cell lines through multiple omic approaches , 2017, Breast cancer research : BCR.

[8]  Piet A van den Brandt,et al.  Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta‐analysis , 2017, International journal of cancer.

[9]  R. Klement.  BENEFICIAL EFFECTS OF KETOGENIC DIETS FOR CANCER PATIENTS – A REALIST REVIEW WITH FOCUS ON EVIDENCE AND CONFIRMATION , 2017, bioRxiv.

[10]  J. Rho,et al.  Need for new review of article on ketogenic dietary regimes for cancer patients , 2017, Medical Oncology.

[11]  Jian-feng Dong,et al.  A meta-analysis between dietary carbohydrate intake and colorectal cancer risk: evidence from 17 observational studies , 2017, Bioscience reports.

[12]  J. Griffiths,et al.  The action of β-hydroxybutyrate on the growth, metabolism and global histone H3 acetylation of spontaneous mouse mammary tumours: evidence of a β-hydroxybutyrate paradox , 2017, Cancer & metabolism.

[13]  H. Bertz,et al.  Impact of a 6-week non-energy-restricted ketogenic diet on physical fitness, body composition and biochemical parameters in healthy adults , 2017, Nutrition & Metabolism.

[14]  F. Khuri,et al.  Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth. , 2017, Cell metabolism.

[15]  M. Rinaldo,et al.  Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial , 2017, BMC Cancer.

[16]  Chao Cheng,et al.  Retraction Note to: Metabolic syndrome factors and risk of postoperative depression in high-grade glioma patients in a 1.5-year prospective study , 2014, Medical Oncology.

[17]  D. Xia,et al.  Association between dietary carbohydrate intake, glycemic index and glycemic load, and risk of gastric cancer , 2017, European Journal of Nutrition.

[18]  C. Daniel,et al.  Dietary Patterns in Puerto Rican and Mexican-American Breast Cancer Survivors: A Pilot Study , 2017, Journal of Immigrant and Minority Health.

[19]  M. Ruggiero,et al.  Clinical Observation of a Novel, Complementary, Immunotherapeutic Approach based on Ketogenic Diet, Chondroitin Sulfate, Vitamin D 3 , Oleic Acid and a Fermented Milk and Colostrum Product , 2016 .

[20]  Pierre Sonveaux,et al.  Monocarboxylate transporters in the brain and in cancer☆ , 2016, Biochimica et biophysica acta.

[21]  Z. Clemens,et al.  Halted Progression of Soft Palate Cancer in a Patient Treated with the Paleolithic Ketogenic Diet Alone: A 20-months Follow-up , 2016 .

[22]  A. Liman,et al.  Modified Atkins diet in advanced malignancies - final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System , 2016, Nutrition & Metabolism.

[23]  C. Perou,et al.  Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts , 2016, Clinical Cancer Research.

[24]  U. Kämmerer,et al.  Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis , 2016, PloS one.

[25]  Mahdi Rezai,et al.  Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of rates of pathologic complete response and survival , 2016, Journal of chemotherapy.

[26]  L. Hutchins,et al.  Pre-diagnosis blood glucose and prognosis in women with breast cancer , 2016, Cancer & Metabolism.

[27]  R. Sweeney,et al.  Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients , 2016, BMC Research Notes.

[28]  H. Walach,et al.  The development of tumours under a ketogenic diet in association with the novel tumour marker TKTL1: A case series in general practice , 2015, Oncology letters.

[29]  T. Habuchi,et al.  The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis , 2016, Medical Oncology.

[30]  A. Jemal,et al.  Breast cancer statistics, 2015: Convergence of incidence rates between black and white women , 2016, CA: a cancer journal for clinicians.

[31]  M. Brand,et al.  Measurement and Analysis of Extracellular Acid Production to Determine Glycolytic Rate , 2015, Journal of visualized experiments : JoVE.

[32]  Musa A. Jundi,et al.  A Supplemented High-Fat Low-Carbohydrate Diet for the Treatment of Glioblastoma , 2015, Clinical Cancer Research.

[33]  J. Reis-Filho,et al.  Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival , 2015, The Journal of pathology.

[34]  S. Pacini,et al.  Effects of Pre-surgical Vitamin D Supplementation and Ketogenic Diet in a Patient with Recurrent Breast Cancer. , 2015, Anticancer research.

[35]  F. Gu,et al.  High Expression of Pyruvate Kinase M2 is Associated with Chemosensitivity to Epirubicin and 5-Fluorouracil in Breast Cancer , 2015, Journal of Cancer.

[36]  A. Di Leo,et al.  Continued value of adjuvant anthracyclines as treatment for early breast cancer. , 2015, The Lancet. Oncology.

[37]  O. Gires,et al.  TKTL1 expression in human malign and benign cell lines , 2015, BMC Cancer.

[38]  W. Sperl,et al.  Mitochondria: The ketogenic diet--A metabolism-based therapy. , 2015, The international journal of biochemistry & cell biology.

[39]  N. Harbeck,et al.  St. Gallen/Vienna 2015: A Brief Summary of the Consensus Discussion , 2015, Breast Care.

[40]  J. Pernicone,et al.  Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature , 2015, Cancer & Metabolism.

[41]  M. Brand,et al.  The contributions of respiration and glycolysis to extracellular acid production. , 2015, Biochimica et biophysica acta.

[42]  F. Baltazar,et al.  Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer , 2015, Journal of cellular and molecular medicine.

[43]  Nadia Harbeck,et al.  A Brief Summary of the Consensus Discussion , 2015 .

[44]  E. Verdin,et al.  β-hydroxybutyrate: much more than a metabolite. , 2014, Diabetes research and clinical practice.

[45]  P. Scherer,et al.  Hyperglycemia as a Risk Factor for Cancer Progression , 2014, Diabetes & metabolism journal.

[46]  E. Richardsen,et al.  Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival , 2014, PloS one.

[47]  L. Pusztai,et al.  Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential , 2014, Breast Cancer Research.

[48]  T. Vanitallie,et al.  Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester , 2014, Journal of Lipid Research.

[49]  R. Powers,et al.  Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia , 2014, Cancer & metabolism.

[50]  Joon Jeong,et al.  In vitro chemoresponse assay based on the intrinsic subtypes in breast cancer. , 2014, Japanese journal of clinical oncology.

[51]  M. Michalczyk,et al.  The Effects of a Ketogenic Diet on Exercise Metabolism and Physical Performance in Off-Road Cyclists , 2014, Nutrients.

[52]  T. Seyfried,et al.  Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer , 2014, International journal of cancer.

[53]  M. Weller,et al.  ERGO: A pilot study of ketogenic diet in recurrent glioblastoma , 2014, International journal of oncology.

[54]  O. Griffith,et al.  COSMIC (Catalogue of Somatic Mutations in Cancer) , 2014 .

[55]  James J. Evans,et al.  Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme , 2014, Journal of Neuro-Oncology.

[56]  G. Parisi,et al.  UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation , 2014, Proceedings of the National Academy of Sciences.

[57]  A. Bianco,et al.  Long Term Successful Weight Loss with a Combination Biphasic Ketogenic Mediterranean Diet and Mediterranean Diet Maintenance Protocol , 2013, Nutrients.

[58]  L. Olson,et al.  Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy , 2013, Nutrition & Metabolism.

[59]  Brian J. Smith,et al.  Ketogenic Diets Enhance Oxidative Stress and Radio-Chemo-Therapy Responses in Lung Cancer Xenografts , 2013, Clinical Cancer Research.

[60]  T. Seyfried,et al.  The Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong Survival in Mice with Systemic Metastatic Cancer , 2013, PloS one.

[61]  Jihyun Lee,et al.  Correlation between the molecular subtype of breast cancer and the in vitro adenosine triphosphate-based chemosensitivity assay , 2013, Journal of the Korean Surgical Society.

[62]  F. Sotgia,et al.  Ketone body utilization drives tumor growth and metastasis , 2012, Cell cycle.

[63]  F. Sotgia,et al.  Ketone bodies and two-compartment tumor metabolism: Stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cells , 2012, Cell cycle.

[64]  A. Negassa,et al.  Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. , 2012, Nutrition.

[65]  L. Rasmussen,et al.  Alterations of monocarboxylate transporter densities during hypoxia in brain and breast tumour cells , 2012, Cellular Oncology.

[66]  Yuanyuan Zhang,et al.  Sequential versus concurrent anthracyclines and taxanes as adjuvant chemotherapy of early breast cancer: a meta-analysis of phase III randomized control trials. , 2012, Breast.

[67]  P. Stafford,et al.  The Ketogenic Diet Is an Effective Adjuvant to Radiation Therapy for the Treatment of Malignant Glioma , 2012, PloS one.

[68]  A. Halestrap.  The monocarboxylate transporter family—Structure and functional characterization , 2012, IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology.

[69]  U. Kämmerer,et al.  Is there a role for carbohydrate restriction in the treatment and prevention of cancer? , 2011, Nutrition & metabolism.

[70]  A. Paoli,et al.  Effect of ketogenic mediterranean diet with phytoextracts and low carbohydrates/high-protein meals on weight, cardiovascular risk factors, body composition and diet compliance in Italian council employees , 2011, Nutrition journal.

[71]  Valerie Speirs,et al.  Choosing the right cell line for breast cancer research , 2011, Breast Cancer Research.

[72]  Mélanie Schmidt,et al.  Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial , 2011, Nutrition & metabolism.

[73]  E. Hattingen,et al.  Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy , 2011, BMC Cancer.

[74]  A. Tsirigos,et al.  Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer , 2011, Cell cycle.

[75]  A. Tsirigos,et al.  Ketones and lactate “fuel” tumor growth and metastasis , 2010, Cell cycle.

[76]  C. Thompson,et al.  Glutamine addiction: a new therapeutic target in cancer. , 2010, Trends in biochemical sciences.

[77]  A. Longatto-Filho,et al.  Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44 , 2010, Journal of biomedicine & biotechnology.

[78]  T. Seyfried,et al.  Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report , 2010, Nutrition & metabolism.

[79]  M. Hung,et al.  The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines , 2010, Breast cancer : basic and clinical research.

[80]  Bonggi Lee,et al.  High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation , 2010, Breast Cancer Research and Treatment.

[81]  P. Febbo,et al.  The Effects of Varying Dietary Carbohydrate and Fat Content on Survival in a Murine LNCaP Prostate Cancer Xenograft Model , 2009, Cancer Prevention Research.

[82]  R. Feinman,et al.  Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2 , 2009, Cancer Cell International.

[83]  E. Beierle,et al.  Ketone bodies inhibit the viability of human neuroblastoma cells. , 2009, Journal of pediatric surgery.

[84]  J. Wheless.  History of the ketogenic diet , 2008, Epilepsia.

[85]  A. Muñoz-serrano,et al.  Spanish Ketogenic Mediterranean diet: a healthy cardiovascular diet for weight loss , 2008, Nutrition Journal.

[86]  J. Rho,et al.  The ketogenic diet and epilepsy , 2008, Current opinion in clinical nutrition and metabolic care.

[87]  R. Nagai,et al.  Expression of two isozymes of acyl‐coenzyme A: Cholesterol acyltransferase‐1 and ‐2 in clear cell type renal cell carcinoma , 2008, International journal of urology : official journal of the Japanese Urological Association.

[88]  R. Wittig,et al.  Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides , 2008, BMC Cancer.

[89]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[90]  R. Chatterjee.  When 60 Lines Don't Add Up , 2007, Science.

[91]  Rhitu Chatterjee,et al.  Cases of Mistaken Identity , 2007, Science.

[92]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[93]  George F Cahill,et al.  Fuel metabolism in starvation. , 2006, Annual review of nutrition.

[94]  M. Milella,et al.  Benefit of taxanes as adjuvant chemotherapy for early breast cancer , 2006, Cancer.

[95]  J. Best,et al.  Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer , 2005, Journal of cellular physiology.

[96]  O. Warburg.  Über den Stoffwechsel der Carcinomzelle , 1924, Naturwissenschaften.

[97]  A. Bonen,et al.  Monocarboxylate transporters in subsarcolemmal and intermyofibrillar mitochondria. , 2004, Biochemical and biophysical research communications.

[98]  M. Yashiro,et al.  Growth-inhibitory effects of the ketone body, monoacetoacetin, on human gastric cancer cells with succinyl-CoA: 3-oxoacid CoA-transferase (SCOT) deficiency. , 2004, Anticancer research.

[99]  Y. Bo-Abbas,et al.  Long-term effects of a ketogenic diet in obese patients. , 2004, Experimental and clinical cardiology.

[100]  T. Seyfried,et al.  Role of glucose and ketone bodies in the metabolic control of experimental brain cancer , 2003, British Journal of Cancer.

[101]  R. Veech,et al.  Ketoacids? Good medicine? , 2003, Transactions of the American Clinical and Climatological Association.

[102]  A. Srivastava,et al.  Chronic exposure to beta-hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes. , 2001, American journal of physiology. Endocrinology and metabolism.

[103]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[104]  P Vaupel,et al.  Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. , 2001, Seminars in oncology.

[105]  Britton Chance,et al.  Ketone Bodies, Potential Therapeutic Uses , 2001, IUBMB life.

[106]  Jullie W Pan,et al.  Human Brain β-Hydroxybutyrate and Lactate Increase in Fasting-Induced Ketosis , 2000 .

[107]  S. Bröer,et al.  The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. , 2000, The Biochemical journal.

[108]  K. Behar,et al.  Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis. , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[109]  A. Jemal,et al.  Breast Cancer Statistics , 2013 .

[110]  L. Laffel.  Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes , 1999, Diabetes/metabolism research and reviews.

[111]  A. Bröer,et al.  Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. , 1999, The Biochemical journal.

[112]  P. Mallmann,et al.  Chemosensibilitätstestungen in der gynäkologischen Onkologie , 1996 .

[113]  L. Nebeling,et al.  Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. , 1995, Journal of the American College of Nutrition.

[114]  P Vaupel,et al.  Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. , 1991, Cancer research.

[115]  M. Patel,et al.  Ketone-body metabolism in glioma and neuroblastoma cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[116]  A. Rofe,et al.  The inhibition of malignant cell growth by ketone bodies. , 1979, The Australian journal of experimental biology and medical science.

[117]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[118]  J. Mitchison.  Cell Biology , 1964, Nature.

[119]  O. Warburg.  On respiratory impairment in cancer cells. , 1956, Science.